Dr. Ailloni-Charas is the CEO and Managing Partner of the Global Health Impact Fund(GHIF), a venture fund focused on investing in early stage healthcare innovation. Global Health Impact Fund is a Strategic Venture Capital Investment Network that is physician-led and physician-driven and leverages the expertise of large networks of physicians and domain experts with its proprietary, data science platform. The insights and experiences of the physician leaders, filter through the analytical engine provide the basis for improved investing outcomes by allowing for better understanding of the clinical and business challenges early stage healthcare startups encounter.

Their investor-focused model invests exclusively on behalf of clinician and healthcare professional investor network. They provide an opportunity for these professionals to participate in a diversified portfolio of early-stage healthcare technology companies. These businesses are revolutionizing the healthcare industry, but the vast majority of clinical professionals are simply observers to changes that will upset their practices and worldview. GHIF offers a potent alternative to that scenario. 

Their network isn’t a passive investor base – GHIF investors will directly help shape the technological cutting edge as executive advisors to the Fund. Their typical prospective investment will be seeking between $250K and $2M in capital. For businesses looking for more than $2M in capital, they have the flexibility to co-invest alongside other strategic venture partners who meet our standards for commitment to healthcare improvement.